A brand new law will bring financial relief to hundreds of thousands of Minnesotans dealing with diabetes and asthma. The law ...

A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1.

Insulin human is under clinical development by Aerami Therapeutics and currently in Phase II for Type 2 Diabetes.

Online Casino in India The next territory of K drug in China Latest! Tianmai Biotech Oral Insulin Capsules Announces Latest Clinical Trial Results Primetals Pharmaceuticals' "Budesonide Suspension for ...

INR:1909. bye full form 18 injections and 1 inhalation were newly announced. This Sichuan company made great efforts Discontinuation of insulin reverses type 1 diab ...

MUMBAI:Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market inhaled insulin in the country, the drugmaker said on Wednesday. The ...

Research analysts at Leerink Partnrs cut their FY2026 earnings per share estimates for MannKind in a research note issued on ...

The pharmacokinetic profile of inhaled insulin has both advantages and disadvantages compared with subcutaneous insulin injection. Because inhaled insulin is more quickly absorbed, pulmonary ...

Positive phase 3 data for inhaled insulin Afrezza Inhalation Powder (MannKind Corporation) in children and adolescents aged 4 to 17 years has been announced by MannKind Corporation. 1 According to the ...

MannKind Corporation, a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced six-month ...

Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled human insulin (Afrezza Inhalation Powder).

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...